Navigation Links
The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
Date:5/22/2013

tients with such unmet medical needs, What makes this project even more exciting to support is that the technology was developed by Professor Sherie Morrison at UCLA while she was funded by a LLS Translational Research Grant.  LLS continues to find that funding through its research grant programs leads to discoveries that move on to biotechnology companies like Valor Biotherapeutics, LLC, who are more fully able to bring novel therapeutics to patients with blood cancer." 

Dr. Rahul Singhvi , chief executive officer of Valor Biotherapeutics, stated:  "We thank LLS for their commitment to our antibody-interferon fusion platform and their crucial financial support of the IGN002 program.  This funding represents a substantial investment in the development of IGN002 and will enable its development through Phase 1 clinical testing.  In addition, we welcome the opportunity to work with LLS and benefit from their vast experience in the lymphoma area as we advance IGN002 into clinical trials."

"IGN002 has demonstrated dramatic efficacy in rituximab-resistant preclinical models. The financial commitment by our JV partner, Caliber and the LLS will help in advancing this program to the proof-of-concept study in NHL patients.  Our R&D team is very excited to work with the LLS and Valor, to advance IGN002 to the clinic," said Sanjay D. Khare , Ph.D., president and CEO of ImmunGene, Inc. "This study will help us in understanding the utility of the technology for several other programs in the ImmunGene pipeline."

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS fun
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Leading Leukemia Experts: High Leukemia Treatment Costs May Be Harming Patients
2. Tosedostat OPAL Study in Acute Myeloid Leukemia Published in Lancet Oncology
3. Launch Of Premium-priced, Novel Targeted Therapies Will Drive Growth In The Acute Leukemia Markets Beginning In 2015
4. The Leukemia & Lymphoma Society and Avella Specialty Pharmacy to Present Free Event on Oral Chemotherapy Drugs
5. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
6. Burlington Coat Factory Completes Another Record Year of Supporting The Leukemia & Lymphoma Society in its Quest to Beat Cancer
7. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
8. Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
9. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
10. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
11. Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... CRY ), a leading medical device and tissue ... today its results for the second quarter and first ... Chairman, President and Chief Executive Officer, said, "During the ... with solid progress on several of our top organizational ... a direct sales model in France, advancing our strategic ...
(Date:7/28/2015)... Minn. , July 28, 2015 ANI ... the Company plans to release its second quarter and ... before the opening of the U.S. financial markets. The ... Relations section of the Company,s website, www.anipharmaceuticals.com . ... Chief Executive Officer, and Charlotte C. Arnold , ...
(Date:7/28/2015)... Oncology, Inc. (OTC: CSBR), engaged in the development of ... and use of oncology drugs, today announced its financial ... Fourth Quarter and Recent Business Highlights: , ... period result , Procured a quarterly record high ... Champions Oncology CEO, stated, "The end of fiscal 2015 ...
Breaking Medicine Technology:CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 3Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 4Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 5Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 6Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 7Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 8Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 9Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 10Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 11
(Date:7/28/2015)... ... ... Egg freezing is becoming an increasingly popular option for family ... Dr. Michael Kettel explained in an article from the San Diego Union-Tribune ... generations who had to make choices between their fertility and their career or personal ...
(Date:7/28/2015)... ... ... According to WFTV on July 15th heroin overdose rates have ... According to recent statistic Orlando suffers at least one death weekly as a direct ... and law enforcement officials are struggling to keep apace with its distribution. Officers rely ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... Directors has authorized the Company, from time to time and depending on market ... of up to $25 million. Repurchases will be made in open market or ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... Every ... professionals or to use extreme caution when lighting fireworks in their own neighborhoods. Unfortunately, ... and discussed in a July 3, 2015 USA Today article " Eye Injuries Caused ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... has won the 2015 NCW Eco-Excellence Award for the Nutrition Beverage category. Established ... lifestyle industries and elevate companies that stand out for their social and environmental ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3Health News:Coco Libre Wins 2015 NCW Eco-Excellence Award 2
... 6 a $5 million investment through the Texas Emerging Technology ... at Houston to launch a new trauma research center led ... for Translational Injury Research (CeTIR) will open in September. , ... of 1 and 44. Every year, injury accounts for 16,000 ...
... 14th,the Aspen Institute Health Stewardship Project will release ... Obama, and Hillary,Rodham Clinton, to a questionnaire on ... provide analysis of the candidates, responses,and discuss the ... Zogby,International., The co-chairs will comment on where ...
... CNN Anchor Soledad O,Brien served as Master of ... for Lupus, Gala raised nearly $1.5 million ... 8 Grammy Award-winning,performer Patti LaBelle entertained a ... of America Awards Gala last night with her ...
... have devoted countless years of collective brainpower to rescuing ... week researchers at the University of Washington will try ... discoveries, perhaps even finding a cure for HIV., A ... competitive sport. Introductory levels teach the rules, which are ...
... Receive this Honor, AUSTIN, Texas, May 8 ... that the hospital network was,selected as one of three ... honor bestowed by the State of Texas based upon,world ... Quality Texas Foundation, is based on St.,David,s HealthCare,s commitment ...
... self-contained breathing,apparatus (SCBA), designed by Draeger Safety, ... the new tough NFPA 1982, 2007 standards ... everyday., (Photo: http://www.newscom.com/cgi-bin/prnh/20080508/NETH078 ), ... apparatus provides,a high level of protection in ...
Cached Medicine News:Health News:Lt. Gov. David Dewhurst announces $5M TETF investment in UTHSC-H trauma research 2Health News:Lt. Gov. David Dewhurst announces $5M TETF investment in UTHSC-H trauma research 3Health News:Lt. Gov. David Dewhurst announces $5M TETF investment in UTHSC-H trauma research 4Health News:Patti LaBelle Wows Crowd at 5th Annual Lupus Foundation of America Awards Gala 2Health News:Patti LaBelle Wows Crowd at 5th Annual Lupus Foundation of America Awards Gala 3Health News:Computer game's high score could earn the Nobel Prize in medicine 2Health News:Computer game's high score could earn the Nobel Prize in medicine 3Health News:Computer game's high score could earn the Nobel Prize in medicine 4Health News:St. David's HealthCare Granted the State's Top Honor for Quality and Performance Excellence 2Health News:St. David's HealthCare Granted the State's Top Honor for Quality and Performance Excellence 3Health News:Draeger Introduces the AirBoss Series Self-Contained Breathing Apparatus Approved to: NFPA 1981, 2007 Standards 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: